Real-time enrollment status for this myeloid malignancies clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 5:00 AM UTC
| NCT Number | NCT04771130 |
| Recruiting Status | Recruiting |
| Condition | Myeloid Malignancies |
| Phase | PHASE1 |
| Target Enrollment | 260 participants |
| Active Locations | 5 sites in the US |
| Sponsor | BeiGene |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 17, 2026: Clinical trial NCT04771130 is currently recruiting participants. This phase1 study for myeloid malignancies is actively seeking new participants at 5 locations across the United States. The study is sponsored by BeiGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04771130 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04771130 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.